Abstract
The pNR-2/pS2 protein is regulated by oestrogens in breast cancer cell lines. This report describes a systematic survey of pNR-2/pS2 expression in a number of common epithelial tumours. Expression was evaluated immunohistochemically in an archival series using antisera raised against the C-terminus of the pNR-2/pS2 protein. Expression of pNR-2/pS2 by malignant epithelial tumours was widespread. Intense immunohistochemical staining was found in tumour cells in a proportion of pancreatic (6/8), large intestinal (7/12), gastric (9/16) and endometrial (4/12) carcinomas. Positive staining for the pNR-2/pS2 protein was also found in both benign and malignant ovarian epithelial tumours and was very significantly associated with mucinous differentiation (P less than 0.00001). Small numbers of carcinomas of bladder (2/10) and prostate (2/7) showed less intense staining and single examples of cervical carcinoma (1/7) and lung carcinoma (1/19) stained positively. None of the renal carcinomas (0/16) examined stained positively. Positive staining showed no correlation with gender. Although there are reports of oestrogen receptor expression in most of the tumour types considered, the possibility of other regulatory influences must also be considered. The pNR-2/pS2 protein may well have a more general role in human epithelial neoplasia than hitherto realised.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Henry, J., Bennett, M., Piggott, N. et al. Expression of the pNR-2/pS2 protein in diverse human epithelial tumours. Br J Cancer 64, 677–682 (1991). https://doi.org/10.1038/bjc.1991.380
Issue Date:
DOI: https://doi.org/10.1038/bjc.1991.380
This article is cited by
-
BC-DETECT: combined detection of serum HE4 and TFF3 improves breast cancer diagnostic efficacy
Breast Cancer (2022)
-
Serum TFF1 and TFF3 but not TFF2 are higher in women with breast cancer than in women without breast cancer
Scientific Reports (2017)
-
Functional expression of recombinant human trefoil factor 1 by Escherichia coli and Brevibacillus choshinensis
BMC Biotechnology (2015)
-
GATA Factors in Gastrointestinal Malignancy
World Journal of Surgery (2011)
-
A second trefoil protein, ITF/hP1.B, is transcribed in human breast cancer
Breast Cancer Research and Treatment (1996)